AbbVie (ABBV) Sale and Maturity of Investments (2012 - 2025)
AbbVie (ABBV) recorded Sale and Maturity of Investments - Total of $34 million in Q4 2025, down 12.8% from $39 million a year earlier.
Powered by 
Analysis
AbbVie (ABBV) Sale and Maturity of Investments (2012 - 2025) Analysis & Trends
For FY2025, AbbVie reported Sale and Maturity of Investments - Total of $76 million, down 86.3% from FY2024.
- Annual Sale and Maturity of Investments - Total has a five-year compound annual growth rate of -45.1% (FY2020 to FY2025).
- Across earlier years, Sale and Maturity of Investments - Total came in at $555 million in FY2024 (+909.1%), $55 million in FY2023 (-96.4%), $1.53 billion in FY2022 and $98 million in FY2021 (-93.6%).
- Quarterly Sale and Maturity of Investments - Total has ranged from $3 million in Q2 2024 to $1.41 billion in Q3 2022 over the past five years.
- On a year-over-year basis, Sale and Maturity of Investments - Total rose in three of the last seven quarters, with growth averaging 68.8%.
- Peak year-over-year performance for Sale and Maturity of Investments - Total in the last five years was growth of 600.0% in Q4 2022, against a decline of 99.6% in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $3 million (Q3 2025), $7 million (Q2 2025) and $32 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Investments Sold (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | 308.00 Mn |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | - |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 405.00 Mn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | 88.00 Mn |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | - |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 2.53 Bn |
| 10 | Vertex Pharmaceuticals | 138.73 Bn | 110.72 Bn | 2.91 Bn | 4.16 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 34.00 Mn |
| Sep 30, 2025 | 3.00 Mn |
| Jun 30, 2025 | 7.00 Mn |
| Mar 31, 2025 | 32.00 Mn |
| Dec 31, 2024 | 39.00 Mn |
| Sep 30, 2024 | 507.00 Mn |
| Jun 30, 2024 | 3.00 Mn |
| Mar 31, 2024 | 6.00 Mn |
| Dec 31, 2023 | 14.00 Mn |
| Sep 30, 2023 | 5.00 Mn |
| Jun 30, 2023 | 14.00 Mn |
| Mar 31, 2023 | 22.00 Mn |
| Dec 31, 2022 | 70.00 Mn |
| Sep 30, 2022 | 1.41 Bn |
| Jun 30, 2022 | 42.00 Mn |
| Mar 31, 2022 | 8.00 Mn |
| Dec 31, 2021 | 10.00 Mn |
| Sep 30, 2021 | 23.00 Mn |
| Jun 30, 2021 | 54.00 Mn |
| Mar 31, 2021 | 11.00 Mn |
API Access
AbbVie Sale and Maturity of Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=ABBV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "sale-and-maturity-of-investments", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();